POLISCOPE
Back to bills

The civic record

Read. Follow. Verify.

North Carolina requires prescription drug advertisements to disclose FDA approval dates and clinical trial…

Original title: Pharmaceutical Full Disclosure Act.

Last action · February 11, 2025: Ref To Com On Rules, Calendar, and Operations of the House (House action)Sponsors: Harry Warren and 11 others

Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Public stanceCommunity reactions are separate from the official record and reporting.

What This Bill Would Do

North Carolina requires prescription drug and manufacturers to include FDA approval dates, first-market dates, and specific details in consumer advertisements published in the state on or after October 1, 2025.

Why it matters

Consumers viewing prescription drug ads in North Carolina will receive expanded disclosure requirements regarding side effect frequencies, trial lengths, and participant counts.

Background
  • Prescription drug advertising is primarily regulated at the federal level by the Food and Drug Administration under the Federal Food, Drug, and Cosmetic Act. context

Who It Would Affect

Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.

Directly affected

Manufacturers of prescription drugs

Prescription drug manufacturers must update all consumer-facing advertisements in North Carolina to include FDA approval dates, market availability dates, and specific clinical trial metrics.

Directly affected

Consumers located in North Carolina

Consumers will see expanded risk disclosures, trial participant counts, trial lengths, and approval dates in prescription drug advertisements.

Key Facts

  • Manufacturers must include the FDA approval date for the advertised use in any regulated prescription drug or biological product advertisement.
  • Advertisements must disclose the date the product was first available for purchase by consumers in the United States.
  • Advertisements listing side effects under federal law must include the length of the clinical trial evidencing the side effect.
  • Advertisements must disclose the number of participants in the clinical trial.
Show all 9 facts
  • Advertisements must state the frequency of the listed side effect by participant number or percentage.
  • Biological products include viruses, therapeutic serums, toxins, antitoxins, vaccines, blood components, allergenic products, and proteins.
  • A clinical trial is defined as an investigation involving human subjects to test efficacy intended for FDA submission.
  • Regulated advertisements cover consumer-facing commercial messages via television, radio, internet, and print in North Carolina.
  • The requirements apply to advertisements published in North Carolina on or after October 1, 2025.

Frequently Asked Questions

When do these advertising requirements take effect?
The act is effective when it becomes law and applies to advertisements published in North Carolina on or after October 1, 2025.
Which media types are covered by the advertising rules?
s include commercial messages made through television, radio, internet, and print media directed at consumers in North Carolina.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Where This Stands

Currently in committee. The next step in the legislative lifecycle is Floor Vote.

Procedural history

3 actions
  1. Feb 11, 2025House
    Ref To Com On Rules, Calendar, and Operations of the House
  2. Feb 11, 2025House
    Passed 1st Reading
  3. Feb 10, 2025HouseIntroduced
    Filed

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Sponsors

Discoveries

1 pattern noticed across the record

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift95% confidence

State-Level Pharmaceutical Advertising Mandates

The bill establishes specific state-level clinical trial disclosure requirements for prescription drug advertisements that build upon federal standards.

Connected Entities

Food and Drug Administration
OrganizationFood and Drug Administration“Federal agency responsible for drug approvals and clinical investigation definit”Map →

Sources

Analysis Score

0–100
  • Significance65
    How much this matters to a regular citizen
  • Controversy40
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz35
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record